Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stijn Servaes

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Brain Communications|March 14, 2024
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak stagingArthur C Macedo, Joseph Therriault, Cécile Tissot, et al.
Nature Communications|July 2, 2025
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer's diseaseFrancieli Rohden, Pamela C L Ferreira, Bruna Bellaver, et al.
Journal of Neuroinflammation|November 24, 2023
14-3-3 <math> </math>-reported early synaptic injury in Alzheimer's disease is independently mediated by sTREM2Marcel S Woo, Johanna Nilsson, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 3, 2023
Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-β positive individualsMarcel S Woo, Cécile Tissot, Juan Lantero-Rodriguez, et al.
Research Square|February 13, 2023
Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer's diseaseTharick Pascoal, Bruna Bellaver, Guilherme Povala, et al.
Molecular Neurodegeneration|January 7, 2024
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathologyJoseph Therriault, Marcel S Woo, Gemma Salvadó, et al.
Ebiomedicine|February 8, 2022
Comparing tau status determined via plasma pTau181, pTau231 and [<sup>18</sup>F]MK6240 tau-PETCécile Tissot, Joseph Therriault, Peter Kunach, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMarcel Seungsu Woo, Joseph Therriault, Yi-Ting Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
APOE ɛ4 carriership determines a faster plasma p-tau217 progression in Aβ-positive individualsMarcel S Woo, Arthur C Macedo, Seyyed Ali Hosseini, et al.
Scientific Reports|October 28, 2025
Equivalence of the FCSRT and RAVLT to detect medial Temporal lobe atrophy and tauopathyEtienne Aumont, Kelly Amiel, Delphine Oliva Lopez, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Brain Communications|March 14, 2024
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak stagingArthur C Macedo, Joseph Therriault, Cécile Tissot, et al.
Nature Communications|July 2, 2025
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer's diseaseFrancieli Rohden, Pamela C L Ferreira, Bruna Bellaver, et al.
Journal of Neuroinflammation|November 24, 2023
14-3-3 <math> </math>-reported early synaptic injury in Alzheimer's disease is independently mediated by sTREM2Marcel S Woo, Johanna Nilsson, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 3, 2023
Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-β positive individualsMarcel S Woo, Cécile Tissot, Juan Lantero-Rodriguez, et al.
Research Square|February 13, 2023
Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer's diseaseTharick Pascoal, Bruna Bellaver, Guilherme Povala, et al.
Molecular Neurodegeneration|January 7, 2024
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathologyJoseph Therriault, Marcel S Woo, Gemma Salvadó, et al.
Ebiomedicine|February 8, 2022
Comparing tau status determined via plasma pTau181, pTau231 and [<sup>18</sup>F]MK6240 tau-PETCécile Tissot, Joseph Therriault, Peter Kunach, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMarcel Seungsu Woo, Joseph Therriault, Yi-Ting Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
APOE ɛ4 carriership determines a faster plasma p-tau217 progression in Aβ-positive individualsMarcel S Woo, Arthur C Macedo, Seyyed Ali Hosseini, et al.
Scientific Reports|October 28, 2025
Equivalence of the FCSRT and RAVLT to detect medial Temporal lobe atrophy and tauopathyEtienne Aumont, Kelly Amiel, Delphine Oliva Lopez, et al.
Pageof 10